Gerstner Sloan-Kettering - Graduate School of Biomedical Sciences
HomeContact UsNewsOnline Application
News
Research News
dispatch @ sloankettering. edu
Sign Up for E-Mail Alerts
Welcome
Program of Study
Faculty/Research
Curriculum
Admissions
Student Life
FAQs
Summer Undergraduate Research Program
News

Research News


February 8, 2012 - Structural biologist Stephen Long talks about how his team used x-ray crystallography to discover the structure of an ion channel called K2P1.
February 1, 2012 - Memorial Sloan-Kettering researchers have performed the first large-scale genetic analysis of several pediatric cancers, identifying mutations and potential targets for therapies to treat the cancers.
Center News, December 2011 - German-born cancer biologist Hans-Guido Wendel is taking advantage of transformative advances in genomics technology to understand key genetic abnormalities in leukemia and lymphoma.
Center News, December 2011 - Years of innovative research, technology development, and facility expansion at Memorial Sloan-Kettering have led to several new experimental treatments for people with cancer.
December 13, 2011 - Scientists have generated a compound that could potentially be used to create a new type of pain medication that may prevent the side effects of currently available painkillers.
Center News, December 2011 - A new therapy tested in mouse models appears to harness neutrophils, a type of white blood cell, to effectively prevent the spread of breast cancer cells.
December 2, 2011 - Recent findings by Memorial Sloan-Kettering investigators suggest it might be possible to improve the effectiveness of chemotherapy for breast cancer by combining the treatment with a new type of drug called a cathepsin inhibitor.
Center News, October 2011 - A glimpse into the minds of three of the Memorial Sloan-Kettering's young faculty members: Morgan Huse, of the Sloan-Kettering Institute's Immunology Program; Ronglai Shen, of the Department of Epidemiology and Biostatistics; and Diane Reidy-Lagunes, of the Department of Medicine.
Center News, October 2011 - A study led by researchers at Memorial Sloan-Kettering and New York University has shown that TET2 loss enhances the function of blood stem cells, causing them to renew themselves more efficiently than normal blood stem cells.
Center News, October 2011 - In a large-scale genomic analysis of the most common and aggressive type of ovarian cancer, researchers from Memorial Sloan-Kettering and other centers identified genetic mutations and pathways that set the disease apart from other types of ovarian cancer and other solid tumors.
Center News, July 2011 - Memorial Sloan-Kettering developmental biologist Maria Jasin and her colleagues have recently published several studies that provide new insights into a biological process that is fundamental to life but can lead to cancer or other conditions when it malfunctions.
Center News, July 2011 - Charles L. Sawyers, Chair of the Human Oncology and Pathogenesis Program, is a co-recipient of the 2011 Stanley J. Korsmeyer Award from the American Society for Clinical Investigation.
Center News, July 2011 - Memorial Sloan-Kettering researchers have discovered that the AR and PI3K disease pathways regulate each other through reciprocal negative feedback.
Center News, July 2011 - Memorial Sloan-Kettering Cancer Center researchers have identified a feature in the DNA of breast cancer cells that might indicate the likelihood a woman's disease will become life threatening.
New York, NY, June 30, 2011 - Researchers at Memorial Sloan-Kettering Cancer Center and New York University have discovered how a mutation in the gene known as TET2 contributes to the development of some leukemias. When a mutation in TET2 occurs, it enhances the function of blood stem cells in the bone marrow, causing them to renew themselves more efficiently than normal blood stem cells. This results in a greater number of mutant cells than normal blood stem cells, a condition that leads to leukemia.
Center News, April 2011 - Memorial Sloan-Kettering physicians have experience and specialized expertise in caring for people with uncommon cancers.
Center News, April 2011 - Memorial Sloan-Kettering Cancer Center researchers have published new findings that may help explain why brain tumors called glioblastomas are so resistant to treatment.
Center News, April 2011 - A new center at the Sloan-Kettering Institute is exploring the potential of embryonic stem cells and human adult cells to produce regenerative treatments and provide insights into cancer.
Center News, April 2011 - More than 500 high school students and their teachers filled the Rockefeller Research Laboratories to learn about recent discoveries.
Center News, April 2011 - An interdisciplinary team from Memorial Sloan-Kettering Cancer Center has shown how antibiotics can disrupt the normal, healthy balance of microorganisms in the gastrointestinal tract.
Center News, April 2011 - Sloan-Kettering Institute Director Thomas J. Kelly is the co-recipient of the 2010 Louisa Gross Horwitz Prize from Columbia University
New York, NY, March 25, 2011 - The US Food and Drug Administration announced today that the drug ipilimumab (brand name Yervoy) has been approved for the treatment of patients with metastatic melanoma. It is the first drug ever shown to improve overall survival for patients with advanced melanoma.
NEW YORK, NY, January 31, 2011 - Researchers at Memorial Sloan-Kettering Cancer Center's Nanotechnology Center, along with collaborators at Cornell University and Hybrid Silica Technologies, have received approval for their first Investigational New Drug Application (IND) from the US Food and Drug Administration (FDA) for an ultrasmall silica inorganic nanoparticle platform for targeted molecular imaging of cancer, which may be useful for cancer treatment in the future.
Center News, January 2011 - A decade ago, the Sloan-Kettering Institute embarked on an effort to broaden and streamline its research activities.
Center News, January 2011 - Appointed Chair of the Department of Pathology at Memorial Sloan-Kettering in April 2010, Dr. Bastian leads pathologists and clinicians in finding new ways to integrate genetic information with traditional clinical observations to diagnose cancer and guide treatment.
Center News, January 2011 - To take advantage of the growing field of nanotechnology, Memorial Sloan-Kettering has established a Nanotechnology Center.
Center News, January 2011 - A team of researchers led by Memorial Sloan-Kettering immunologist Alexander Rudensky has gained new understanding about regulatory T cells -- a subtype of immune cells that suppresses the immune system's reactivity.
Center News, January 2011 - Zvi Fuks has been elected a member of the Institute of Medicine, one of the highest honors in the fields of health and medicine.
Center News, January 2011 - Three Memorial Sloan-Kettering Cancer Center investigators -- including the Center's new President, Craig B. Thompson -- have been featured with singer-songwriter Debbie Harry to lead the Geoffrey Beene Gives Back® 2010 Rock Stars of Science campaign in GQ magazine's December "Men of the Year" issue.
NEW YORK, NY, November 17, 2010 - An internation, multi-center study has revealed the discovery of a novel oncogene that is associated with uveal melanoma, the most common form of eye cancer. Researchers have isolated an oncogene called GNA11 and have found that it is present in more than 40 percent of tumor samples taken from patients with uveal melanoma.
Center News, October 2010 - A multicenter study led by Memorial Sloan-Kettering researchers has answered an important question about the safety of using carbon nanotubes in medicine.
Center News, October 2010 - As part of a commitment to seek new and better treatments for cancer patients, Memorial Sloan-Kettering Cancer Center and Bristol-Myers Squibb are collaborating to bring a potential new cancer drug called iso-fludelone, or KOS-1803, into clinical trials.
Center News, October 2010 - A member of the Sloan-Kettering Institute's Immunology Program and a Howard Hughes Medical Institute investigator, Alexander Rudensky is fascinated by how a specific type of white blood cells called regulatory T cells regulates our immune system.
NEW YORK, NY, October 1, 2010 - A multi-institutional team led by investigators from Memorial Sloan-Kettering Cancer Center has published a study that provides new insight into genetic changes that make some forms of glioblastoma, the most common type of primary brain cancer, more aggressive than others and explains why they may not respond to certain therapies.
NEW YORK, NY, August 10, 2010 - Craig B. Thompson, MD, has been named the new President and Chief Executive Officer of Memorial Sloan-Kettering Cancer Center effective November 2, 2010.
Center News, July 2010 - Harold Varmus became President and Chief Executive Officer of Memorial Sloan-Kettering Cancer Center on January 1, 2000. He ended his decade-long tenure on July 1, 2010. And on July 12, 2010, Dr. Varmus took up a new role as Director of the National Cancer Institute.
Center News, July 2010 - A team of Memorial Sloan-Kettering researchers reports that prostate cancer often takes an aggressive course in patients who have inherited mutations in the genes BRCA1 or BRCA2.
Center News, July 2010 - A multicenter team led by Memorial Sloan-Kettering neurologist and researcher Ingo K. Mellinghoff has uncovered the relationship between two proteins that play a critical role in glioblastoma, the most common form of brain cancer.
Center News, July 2010 - Physician-scientist Boris C. Bastian joined Memorial Sloan-Kettering as Attending Physician and Chair of the Department of Pathology on April 1.
NEW YORK, NY, June 24, 2010 - A unique collaboration among physician-scientists at Memorial Sloan-Kettering Cancer Center has yielded the most comprehensive genomic analysis of prostate cancer to date. The study, published in the journal Cancer Cell, provides a previously unavailable genomic analysis whose scope and size offers new insight leading to more effective diagnostic tests as well as future treatment options for prostate cancer patients.
Center News, June 2010 - The Metastasis Research Center has brought together 27 Memorial Sloan-Kettering laboratories to facilitate research on metastasis and its treatment.
Center News, June 2010 - A recent Memorial Sloan-Kettering study shows that some circulating tumor cells can circle back and infiltrate their tumor of origin, enhancing its growth and aggressiveness.
Center News, June 2010 - A collaborative team of researchers from Memorial Sloan-Kettering has determined the mechanism for a biological process that plays a key role in regulating cellular behavior.
Center News, June 2010 - Memorial Sloan-Kettering has created a new multidisciplinary research center that promises to shed light on the role that microbes and the body's inflammatory and immunological responses to them play in the development of cancer.
Center News, June 2010 - Memorial Sloan-Kettering has made an important step forward in efficiently diagnosing gene mutations in patients' cancers on an individual basis.
Center News, June 2010 - Charles Sawyers, Chair of Memorial Sloan-Kettering Cancer Center's Human Oncology and Pathogenesis Program, was elected to the National Academy of Sciences at its annual meeting on April 27, 2010.
Center News, February 2010 - Samuel Singer has been appointed Chief of the Gastric and Mixed Tumor Service in the Department of Surgery.
Center News, February 2010 - Hedvig Hricak, Chair of Memorial Sloan-Kettering's Department of Radiology and incumbent of the Carroll and Milton Petrie Chair, has been named the 95th President of the Radiological Society of North America Board of Directors.
Center News, February 2010 - Each year since 2007, Memorial Sloan-Kettering's postdoctoral researchers have had the opportunity to showcase their research accomplishments at the annual Postdoctoral Research Symposium.
Center News, February 2010 - A multidisciplinary team of Memorial Sloan-Kettering investigators has shown for the first time that the gene that causes the inherited form of Parkinson's disease also plays a role in many types of cancer, including colon and lung cancers and glioblastoma, the most common form of brain cancer.
Center News, February 2010 - Cancer biologist Andrea Ventura is the incumbent of a Geoffrey Beene Junior Faculty Chair at the Sloan-Kettering Institute, he devotes his research to the nascent field of microRNA expression, seeking to understand how these small RNAs act on genes to promote or suppress cancer.
Center News, February 2010 - In October 2009, a team of eight researchers, six of whom are at Memorial Sloan-Kettering, received an $11 million, five-year grant from the NCI to form one of 12 Physical Sciences-Oncology Centers (PS-OCs) in the United States
NEW YORK, NY, December 2009 - Cancer progression is commonly thought of as a process involving the growth of a primary tumor followed by metastasis, in which cancer cells leave the primary tumor and spread to distant organs. A new study by researchers at Memorial Sloan-Kettering Cancer Center shows that circulating tumor cells - cancer cells that break away from a primary tumor and disseminate to other areas of the body - can also return to and grow in their tumor of origin, a newly discovered process called "self-seeding."
Center News, December 2009 - Eric C. Holland and Alexandra L. Joyner have been elected members of the Institute of Medicine.
Center News, December 2009 - Memorial Sloan-Kettering researchers have engineered stem cells from patients with familial dysautonomia, a rare genetic disorder, and used them to explore the causes of the disease and to test drugs that might be effective against it.
Center News, December 2009 - Memorial Sloan-Kettering investigators have shown that a new type of cancer vaccine might be more effective than previous therapies at inducing immune cells to destroy tumors.
Center News, December 2009 - Patients with a rare but aggressive form of cancer now have access to a drug that has proven effective after the disease becomes resistant to standard treatments.
Center News, December 2009 - Dr. Powell joined Memorial Sloan-Kettering in 2008 as Chair of the Department of Radiation Oncology with a joint appointment in Sloan-Kettering Institute's Molecular Biology Program.
November 17, 2009 - The Howard Hughes Medical Institute (HHMI) announced that Memorial Sloan-Kettering Cancer Center's Gerstner Sloan-Kettering Graduate School of Biomedical Sciences is one of 23 research institutions to receive a grant as part of HHMI's Med into Grad Initiative.
Center News, October 2009 - Results from studies in cell cultures and mouse models suggest that the experimental targeted therapy PU-H71 may be effective against one of the most aggressive forms of breast cancer.
Center News, October 2009 - Structural biologists at Memorial Sloan-Kettering Cancer Center are collaborating with biochemists and cell biologists at The Rockefeller University to study how cells read genetic instructions imprinted on histones, DNA's packaging proteins.
Center News, October 2009 - A veterinarian who specializes in animals used in biomedical research, Neil Lipman ensures the welfare of Memorial Sloan-Kettering's research animals.
NEW YORK, September 2009 - Memorial Sloan-Kettering Cancer Center physician-scientist Charles L. Sawyers has been named a recipient of the 2009 Lasker~DeBakey Award for Clinical Medical Research.
Center News, July 2009 - A team of researchers led by Memorial Sloan-Kettering physician-scientist Charles L. Sawyers has reported on the preclinical development and early results from the first clinical trial of a promising new drug for prostate cancer.
Center News, July 2009 - Jennifer A. Zallen, a member of the Developmental Biology Program in the Sloan-Kettering Institute, has been selected by the Howard Hughes Medical Institute as an Early Career Scientist.
Center News, July 2009 - Memorial Sloan-Kettering's Boards of Overseers and Managers have announced the creation of the Bristol-Myers Squibb/James D. Robinson III Junior Faculty Chairs and have named the first two incumbents: Sloan-Kettering Institute's Grégoire Altan-Bonnet and Songhai Shi.
Center News, July 2009 - Dinshaw J. Patel, a Member in Sloan-Kettering Institute's Structural Biology Program and incumbent of the Abby Rockefeller Mauzé Chair in Experimental Therapeutics, was elected to the National Academy of Sciences at its 146th annual meeting in April.
Center News, July 2009 - Memorial Sloan-Kettering President Harold Varmus, joined lawmakers, scientists, and patients on March 9 at a White House ceremony as President Barack Obama issued an executive order lifting the strict limits on human embryonic stem cell research.
Center News, July 2009 - Michael Overholtzer is a recent recruit to Sloan-Kettering Institute's Cell Biology Program, he pairs this curiosity with a dedication to finding new ways to control disease.
NEW YORK, July 6, 2009 - New research led by investigators at Memorial Sloan-Kettering Cancer Center sheds light on a genetic function that gives breast cancer cells the ability to survive and spread to the bone years after treatment has been administered.
NEW YORK, July 2, 2009 - A new study by researchers at Memorial Sloan-Kettering Cancer Center reveals the genetic underpinnings of what causes lung cancer to quickly metastasize, or spread, to the brain and the bone - the two most prominent sites of lung cancer relapse.
NEW YORK, May 27, 2009 - Charles Sawyers, MD, Director of the Human Oncology and Pathogenesis Program at Memorial Sloan-Kettering Cancer Center and a Howard Hughes Medical Institute investigator, has been named a "Dream Team" leader by Stand Up To Cancer and will co-lead a collaborative team that will receive $15 million to study targeted therapies to treat women's cancers.
Center News, May 2009 - David A. Scheinberg has been elected a member of the prestigious Association of American Physicians.
Center News, May 2009 - Memorial Sloan-Kettering Cancer Center's Geoffrey Beene Translational Oncology Core Facility was established in 2007 to increase understanding of the genes involved in cancer by taking advantage of the Center's wealth of tumor samples collected from patients.
Center News, May 2009 - Joan Massagué, Chair of the Cancer Biology and Genetics Program in the Sloan-Kettering Institute, has been named the recipient of two prestigious awards. The first is the G.H.A. Clowes Memorial Award, presented by the American Association for Cancer Research, and the second is the Frontiers of Knowledge Award in Biomedicine, presented by the BBVA Foundation.
Center News, May 2009 - Charles L. Sawyers, Chair of the Human Oncology and Pathogenesis Program, has been awarded the 2009 Dorothy P. Landon Prize for Translational Cancer Research from the American Association for Cancer Research.
NEW YORK, May 6, 2009 - New research led by investigators at Memorial Sloan-Kettering Cancer Center identifies three genes that specifically mediate the metastasis, or spread, of breast cancer to the brain and illuminates the mechanisms by which this spread occurs.
NEW YORK, April 9, 2009 - A new multi-center study shows that an experimental drug lowers prostate specific antigen (PSA) levels - a marker for tumor growth - in men with advanced prostate cancer for whom traditional treatment options have failed.
Center News, March 2009 - Memorial Sloan-Kettering Cancer Center investigators have found a new technique to control gene expression in mice.
Center News, March 2009 - Ross L. Levine is an assistant member in the Human Oncology and Pathogenesis Program and holder of a Geoffrey Beene Junior Faculty Chair, he analyzes the genetic makeup of cancer cells to identify disease pathways.
Center News, March 2009 - In February, Harold Varmus' memoir about his life in science was published.
Center News, March 2009 - President Obama appoints Harold Varmus Co-Chair of the President's Council of Advisors on Science and Technology.
Center News, March 2009 - John Maciejowski and Armine Matevossian, share a day in their life as Gerstner Sloan-Kettering students.
NEW YORK, January 9, 2009 - A new study at Memorial Sloan-Kettering sheds light on a little understood biological process called quiescence, which enables blood-forming stem cells to exist in a dormant or inactive state in which they are not growing or dividing.
Center News, December 2008 - Therapies designed to target cancer while sparing healthy tissue show benefit, but have not yet reached full potential.
Center News, December 2008 - Memorial Sloan-Kettering researchers gathered with scientists from four other institutions at Cold Spring Harbor Laboratory on Long Island in September to present and discuss projects funded by the Starr Cancer Consortium.
Center News, December 2008 - Memorial Sloan-Kettering Cancer Center President Harold Varmus was awarded the 2008 Henry G. Friesen International Prize in Health Research on September 24 in Toronto.
Center News, December 2008 - Charles L. Sawyers has been elected a member of the Institute of Medicine of the National Academies.
Center News, December 2008 - Kathryn V. Anderson has been elected a member of the Institute of Medicine of the National Academies.
Center News, December 2008 - Investigators at Memorial Sloan-Kettering Cancer Center have found new clues about how metastatic cancer can form long after a primary tumor has been removed.
Center News, October 2008 - At Memorial Sloan-Kettering, as the genetics revolution continues to flourish, discoveries made in the laboratory are increasingly producing real-world benefits for cancer patients.
NEW YORK, October 9, 2008 - Memorial Sloan-Kettering Cancer Center has announced the gift of a membership interest in Geoffrey Beene, LLC, the company that controls the business and fashion empire created by legendary designer Geoffrey Beene.
Center News, October 2008 - Investigators at Memorial Sloan-Kettering have developed a new tool that could help them advance the understanding of human embryonic stem cells.
Center News, October 2008 - Physician-scientist Michael S. Glickman specializes in the treatment and study of infectious diseases.
Center News, October 2008 - Scott N. Keeney, a member of the Molecular Biology Program within the Sloan-Kettering Institute, was one of 56 researchers to be appointed a Howard Hughes Medical Institute investigator in 2008.
Center News, August 2008 - Marcel R.M. van den Brink has been named Head of the Division of Hematologic Oncology in the Department of Medicine.
Center News, August 2008 - Jason Lewis has joined the Center as Chief of the Radiochemistry Service in the Department of Radiology and an Associate Member in Memorial Sloan-Kettering Cancer Center.
Center News, August 2008 - Simon N. Powell has joined Memorial Sloan-Kettering Cancer Center as Chair of the Department of Radiation Oncology.
June 2008 - Gerstner Sloan-Kettering faculty members' work has been recognized and supported by The Hope Fund for Cancer Research, Searle Scholars Program, and the Rita Allen Foundation.
Center News, May 2008 - Sloan-Kettering Institute Director Thomas J. Kelly has been named a member of the Advisory Committee to the Director (ACD) at the National Institutes of Health.
Center News, May 2008 - Using mice that are genetically engineered to develop prostate cancer in a manner that mimics the formation of human prostate cancers, investigators at Memorial Sloan-Kettering Cancer Center have found a previously unknown immune response to tumor cells.
Center News, May 2008 - Cell biologist Xuejun Jiang's study of the fundamental processes of biology began in China when he was a college student and continued with graduate and postgraduate work in Texas.
NEW YORK, April 3, 2008 - A study led by researchers at Memorial Sloan-Kettering Cancer Center has uncovered how breast tumors use a particular type of molecule to promote metastasis - the spread of cancer cells.
NEW YORK, March 23, 2008 - Research led by investigators at Memorial Sloan-Kettering Cancer Center has shown that therapeutic cloning, also known as somatic-cell nuclear transfer (SCNT), can be used to treat Parkinson's disease in mice.
Center News, March 2008 - Memorial Sloan-Kettering is leading efforts to understand the key genetic changes in many types of cancer.
Center News, March 2008 - In 2005, 15 years after the start of the Human Genome Project and two years after the full human genome sequence was completed, the National Cancer Institute and the National Human Genome Research Institute announced the launch of the pilot phase of The Cancer Genome Atlas. The project seeks to accelerate the understanding of the molecular basis of cancer through the application of a variety of genome analysis technologies.
Center News, March 2008 - Lorenz Studer's professional journey has taken him from humble beginnings in a storage-room-turned-laboratory in his native Switzerland to a state-of-the-art research facility at the Sloan-Kettering Institute, where he studies the use of embryonic stem cells to repair or replace cells that have been lost or damaged through disease.
NEW YORK, March 3, 2008 - An international group of investigators led by scientists at Memorial Sloan-Kettering Cancer Center and the National Cancer Institute has identified a new genetic marker of risk for breast cancer.
NEW YORK, February 29, 2008 - A new study led by researchers at Memorial Sloan-Kettering Cancer Center Reports on a novel mechanism that can enhance the function of a protein that is frequently impaired in patients with acute forms of leukemia.
NEW YORK, January 9, 2008 - Researchers have identified a specific group of microRNA molecules that are responsible for controlling genes that cause breast cancer metastasis.
Center News, January 2008 - More than 100 postdoctoral research fellows showcased their accomplishments at the inaugural Postdoctoral Fellow Research Symposium.
Center News, January 2008 - High school students and teachers flocked to Memorial Sloan-Kettering Cancer Center for second annual research symposium.
Center News, January 2008 - James P. Allison, Chair of the Immunology Program in the Sloan-Kettering Institute, has been elected a member of the Institute of Medicine.
Center News, January 2008 - Charles L. Sawyers, Chair of Memorial Sloan-Kettering's Human Oncology and Pathogenesis Program, is one of 15 patient-oriented researchers to be appointed a Howard Hughes Medical Institute investigator.
Center News, January 2008 - Memorial Sloan-Kettering has established a Brain Tumor Center (BTC) to address the challenges of managing primary brain tumors and brain metastases.
Center News, November 2007 - A week of orientation activities for the second incoming class of students of the Gerstner Sloan-Kettering Graduate School of Biomedical Sciences included a personal welcome from Memorial Sloan-Kettering Cancer Center President Harold Varmus.
Center News, November 2007 - As the head of a laboratory in the Molecular Pharmacology and Chemistry Program at the Sloan-Kettering Institute, Derek Tan is a young leader in the field of chemical biology.
Center News, November 2007 - A collaboration among Memorial Sloan-Kettering molecular biologist Scott Keeney, developmental biologist Maria Jasin, and research fellow Liisa Kauppi has pinpointed sites on chromosomes where genetic material is exchanged between pairs of chromosomes occur before they separate.
Center News, November 2007 - In June, the High-Throughput Screening Facility and its head, biochemist and pharmacologist Hakim Djaballah, won the 2007 Robots and Vision User Recognition Award.
Center News, September 2007 - A team of scientists led by Memorial Sloan-Kettering investigator Gabriela Chiosis has found that Hsp90 enables the disease process in a group of neurodegenerative disorders marked by the accumulation of the protein Tau.
Center News, September 2007 - New research carried out in the laboratory of Memorial Sloan-Kettering molecular biologist John H.J. Petrini has shed light on one mechanism that helps the cell respond to DNA damage and prevent it from being passed on when the cell divides to create new cells.
Center News, September 2007 - The Memorial Sloan-Kettering Center for Cell Engineering was established to take advantage of the important strides made in the genetic engineering of human cells over the past several years.
Center News, September 2007 - Alexandra Joyner recently joined the Sloan-Kettering Institute as a Member of the Developmental Biology Program. She is also the incumbent of the Courtney Steel Chair in Pediatric Cancer Research.
Center News, July 2007 - In 2006, James A. Fagin was appointed Chief of M Memorial Sloan-Kettering's Endocrinology Service and a member of the Human Oncology and Pathogenesis Program. His research has been instrumental in characterizing many of the genetic changes associated with the development and progression of thyroid cancer.
Center News, July 2007 - A team of Memorial Sloan-Kettering investigators has reported for the first time a novel strategy to coax human embryonic stem cells (HESCs) to develop into cells that could potentially be used to repair the musculoskeletal system, including bone, cartilage, and muscle.
Center News, April 2007 - Memorial Sloan-Kettering Cancer Center clinicians and researchers have been at the forefront of developing new ways to guide the body's immune system toward producing a response that targets and destroys cancer cells.
Center News, April 2007 - To facilitate and enhance the work of Center researchers, Memorial Sloan-Kettering Cancer Center maintains a system of core facilities -- specialized laboratories and data centers that offer shared services to multiple users.
Center News, April 2007 - Joan Massagué is the recipient of the 2007 Passano Award for the originality and importance of his work elucidating the mechanism of action for transforming growth factor-beta (TGF-b) signaling.
Center News, April 2007 - Johanna Joyce, of the Sloan-Kettering Institute's Cancer Biology and Genetics Program, has been named the first incumbent of a Geoffrey Beene Junior Faculty Chair.
NEW YORK, April 11, 2007 - Biologists at Memorial Sloan-Kettering Cancer Center have identified a set of genes expressed in human breast cancer cells that work together to remodel the network of blood vessels at the site of the primary tumor.
Center News, February 2007 - Many of Memorial Sloan-Kettering's advances in patient care, research, and education are made by young staff members who are just beginning their careers.
Center News, February 2007 - A team of scientists led by Memorial Sloan-Kettering Cancer Center cancer biologist Robert Benezra has revealed new insights into the mechanism of tumor formation by boosting levels of the Mad2 gene in mice.
Center News, February 2007 - Alexandra Leigh Joyner has been appointed a Member in the Developmental Biology Program in the Sloan-Kettering Institute. She has also been named the incumbent of the Courtney Steel Chair in Pediatric Cancer Research.
NEW YORK, January 12, 2007 -Researchers led by scientists at Memorial Sloan-Kettering Cancer Center have now identified fundamentally novel regulatory mechanisms of PTEN function. The findings from two related studies are published in the January 12 issue of Cell.
NEW YORK, December 7, 2006 - Computational biology researchers today announced a new Internet tool for the exploration of the scientific literature in medicine and biology. The freely accessible iHOP service provides fast, accurate, comprehensive, and up-to-date summary information on more than 80,000 biological molecules by automatically extracting key sentences from millions of PubMed documents when a search is requested.
Center News, December 2006 -Alan Hall, Chair of the Sloan-Kettering Institute's Cell Biology Program, discusses his far-ranging professional journey and explains his research objectives and program goals at Sloan-Kettering Institute.
Center News, December 2006 - A study led by immunologist and Adult Bone Marrow Transplant Service Chief Marcel R. van den Brink has demonstrated a novel strategy for boosting numbers of infection-fighting T cells in mice after allogeneic bone marrow transplantation.
Center News, December 2006 - A collaboration driven by Jayakrishnan Nandakumar, a fifth-year graduate student in the Tri-Institutional Training Program in Chemical Biology, and guided by Sloan-Kettering Institute researchers Christopher Lima and Stewart Shuman, has led to the exquisite visualization of RNA ligase 2 (Rnl2).
Center News, December 2006 - Joan Massagué, Chair of the Cancer Biology and Genetics Program in the Sloan-Kettering Institute, has been elected a member of the Institute of Medicine (IOM).
Center News, November 2006 - Memorial Sloan-Kettering Cancer Center takes a major step into the future, dedicated to answering the critical 21st-century questions about cancer biology and to speeding the translation of basic discoveries into effective therapies for patients.
Center News, November 2006 - Nearly 500 students and teachers from more than 40 New York-area high schools filled the Rockefeller Research Laboratories Auditorium for Major Trends in Modern Cancer Research.
Center News, November 2006 - An overflow crowd of Center staff and the public gathered in the Rockefeller Research Laboratories Auditorium to hear an afternoon of talks, by distinguished guest speakers, entitled Science and Society in the 21st Century.
Center News, November 2006 - A shoulder-to-shoulder crowd of Memorial Sloan-Kettering Cancer Center staff, Board members, and friends of the institution thronged the Cyber Lounge and 69th Street lobby of The Mortimer B. Zuckerman Research Center on September 21 for a program marking its official opening.
Center News, November 2006 - Charles L. Sawyers recently came to Memorial Sloan-Kettering from the University of California, Los Angeles, to lead the new Human Oncology and Pathogenesis Program (HOPP).
Center News, November 2006 - Memorial Sloan-Kettering researchers have demonstrated in mice that red blood cell precursors derived from bone marrow stem cells could be engineered to produce a secreted protein at therapeutic levels over a prolonged period.
Center News, November 2006 - Center researchers report that flavopiridol represents a possible new treatment for gastrointestinal stromal tumor (GIST), the most common sarcoma of the gastrointestinal tract.
NEW YORK, November 14, 2006 — Memorial Sloan-Kettering Cancer Center is one of six leading institutions that will share in a $120 million gift from a foundation created by American billionaire Daniel K. Ludwig.
October 3, 2006 - Graduate School receives NIH Training for an Interdisciplinary Workforce grant.
NEW YORK, September 27, 2006 - A gift from the estate of renowned fashion designer Geoffrey Beene will enable Memorial Sloan-Kettering Cancer Center (MSKCC) to launch an ambitious research initiative to be known as the Geoffrey Beene Cancer Research Center.
NEW YORK, September 21, 2006 - The Starr Foundation today announced that it has made a $100 million grant to create a wide-ranging cancer consortium to coordinate the efforts of five internationally renowned research institutions in the fight against cancer. Joining this ambitious undertaking are The Broad Institute of MIT and Harvard, Cold Spring Harbor Laboratory, Memorial Sloan-Kettering Cancer Center, The Rockefeller University, and Weill Cornell Medical College.
NEW YORK, September 18, 2006 - Memorial Sloan-Kettering Cancer Center (MSKCC) is now poised to take greater advantage of a new era in cancer research and education with the opening of a state-of-the-art research center, the establishment of a new graduate school, and the founding of a novel research program in human oncology.
Center News, September 2006 - Memorial Sloan-Kettering Cancer Center scientists led by cancer biologist Joan Massagué have discovered a new branch in the signaling network of a protein called transforming growth factor-beta (TGF- ).
Center News, September 2006 - Memorial Sloan-Kettering Cancer Center investigators have created two new mouse models of lung adenocarcinoma.
Center News, September 2006 - Memorial Sloan-Kettering has announced the creation of the Molecular Diagnostics Service in the Department of Pathology and named Marc Ladanyi the service's first Chief.
Center News, July 2006 - Physician-scientist Charles L. Sawyers has been appointed Chairman of Memorial Sloan-Kettering Cancer Center's new Human Oncology and Pathogenesis Program (HOPP) and the first incumbent of the Marie Josée and Henry R. Kravis Chair.
NEW YORK, July 31, 2006 - The Tri-Institutional Stem Cell Initiative, comprised of three leading New York City biomedical research institutions has announced the first wave of stem cell research projects to be funded through a $50 million gift from The Starr Foundation. The gift was announced on May 23, 2005.
Center News, July 2006 - Memorial Sloan-Kettering Cancer Center investigators have uncovered new clues about what controls the number of hematopoietic (blood-forming) stem cells (HSCs) and how these cells form the various types of mature circulating blood cells.
Center News, July 2006 - Alan Hall, Chairman of the Cell Biology Program in the Sloan-Kettering Institute, has been honored with a 2006 Gairdner International Award.
Center News, July 2006 - A multi-institutional study led by Memorial Sloan-Kettering Cancer Center suggests a link between childhood chemotherapy and development of a type of kidney cancer.
NEW YORK, May 10, 2006 - Memorial Sloan-Kettering Cancer Center today announced a major commitment from publisher, real estate developer, and Memorial Sloan-Kettering Board member Mortimer B. Zuckerman of $100 million from his charitable trust toward Memorial Sloan-Kettering's new cancer research facility, including a 23-story laboratory structure that opens this month.
Center News, April 2006 - A multidisciplinary team of Memorial Sloan-Kettering Cancer Center investigators has taken a step toward determining which proteins in the blood may indicate the presence of several common types of cancer.
Center News, April 2006 - Center researchers have learned how a particular type of enzyme in cells can be manipulated to combat pancreatic cancer in mice, providing new information that may be used to design better therapies for people.
Center News, April 2006 - The inaugural Vilcek Prize in Biomedical Research has been awarded by The Vilcek Foundation to Joan Massagué, Chairman of the Sloan-Kettering Institute's Cancer Biology and Genetics Program.
Center News, April 2006 - Memorial Sloan-Kettering Cancer Center chemist Samuel J. Danishefsky will be honored with three major awards this spring. Dr. Danishefsky is the incumbent of a Eugene W. Kettering Chair and a member of the Molecular Pharmacology and Chemistry Program in the Sloan-Kettering Institute.
Center News, March 2006 - Gerstner Sloan-Kettering faculty member Joan Massagué and Memorial Sloan-Kettering investigator Dori A. Thomas have published a paper showing how the protein called transforming growth factor-beta (TGF-ß) allows tumor cells to escape killing by the immune system.
Center News, March 2006 - The World Technology Network awarded the 2005 WTN Award in Media and Journalism to Gertsner Sloan-Kettering Graduate School President Harold Varmus and his colleagues at the Public Library of Science; Joan Massagué, Chairman of the Cancer Biology and Genetics Program, is among the recipients of the 2005 New York City Mayor's Awards for Excellence in Science and Technology; Faculty Member Steven Larson has been elected to the Institute of Medicine.
Subscribe to RSS FeedHelp
Print This PageEmail This PageBookmark and Share
gradstudies@sloankettering.eduFacebook
©2014 Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences,
Memorial Sloan-Kettering Cancer Center
1275 York Avenue, Box 441, NY, NY 10065
646.888.6639
Sloan-Kettering InstituteMemorial Sloan-Kettering Cancer Center